Plus Therapeutics (PSTV) Financial Statements

1,715 Followers

Plus Therapeutics Financial Overview

Plus Therapeutics's market cap is currently $41.10M. The company's EPS TTM is $; its P/E ratio is -1.74; Plus Therapeutics is scheduled to report earnings on April 16, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 5.21M	$ 5.82M	$ 4.91M	$ 224.00K	$ 0.00
Gross Profit	$ 4.77M	$ 4.97M	$ -4.78M	$ -488.00K	$ -66.00K
Operating Income	$ -15.30M	$ -14.70M	$ -13.32M	$ -19.71M	$ -12.49M
EBITDA	$ -14.85M	$ -8.40M	$ -12.69M	$ -18.85M	$ -12.05M
Net Income	$ -22.39M	$ -12.98M	$ -13.32M	$ -20.27M	$ -13.40M
Balance Sheet
Cash & Short-Term Investments	$ 8.76M	$ 3.61M	$ 8.55M	$ 18.12M	$ 18.40M
Total Assets	$ 16.32M	$ 6.63M	$ 11.39M	$ 23.87M	$ 21.98M
Total Debt	$ 821.00K	$ 3.37M	$ 4.18M	$ 5.75M	$ 6.99M
Net Debt	$ -7.94M	$ 3.29M	$ -4.37M	$ -12.37M	$ -11.41M
Total Liabilities	$ 12.33M	$ 15.58M	$ 12.74M	$ 17.42M	$ 11.14M
Stockholders' Equity	$ 4.00M	$ -8.95M	$ -1.35M	$ 6.45M	$ 10.84M
Cash Flow
Free Cash Flow	$ -20.84M	$ -10.70M	$ -13.01M	$ -13.73M	$ -10.42M
Operating Cash Flow	$ -20.77M	$ -10.55M	$ -12.85M	$ -12.97M	$ -10.28M
Investing Cash Flow	$ -854.00K	$ -4.11M	$ -160.00K	$ -759.00K	$ -82.00K
Financing Cash Flow	$ 30.31M	$ 6.19M	$ 3.44M	$ 13.45M	$ 20.42M

Currency in USD

Plus Therapeutics Earnings and Revenue History

Income Statement >

Plus Therapeutics Debt to Assets

Balance Sheet >

Plus Therapeutics Cash Flow

Cash Flow >

Plus Therapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >